BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12468272)

  • 1. Identification of the PPARA locus on chromosome 22q13.3 as a modifier gene in familial combined hyperlipidemia.
    Eurlings PM; van der Kallen CJ; Geurts JM; Flavell DM; de Bruin TW
    Mol Genet Metab; 2002 Dec; 77(4):274-81. PubMed ID: 12468272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variants in the PPARgamma gene affect fatty acid and glycerol metabolism in familial combined hyperlipidemia.
    Eurlings PM; van der Kallen CJ; Vermeulen VM; de Bruin TW
    Mol Genet Metab; 2003 Nov; 80(3):296-301. PubMed ID: 14680975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of TNFRSF1B as a novel modifier gene in familial combined hyperlipidemia.
    Geurts JM; Janssen RG; van Greevenbroek MM; van der Kallen CJ; Cantor RM; Bu X; Aouizerat BE; Allayee H; Rotter JI; de Bruin TW
    Hum Mol Genet; 2000 Sep; 9(14):2067-74. PubMed ID: 10958645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of mutations in low density lipoprotein receptor (LDLR) and lipoprotein lipase (LPL) genes to familial combined hyperlipidemia (FCHL): a reappraisal by using a resequencing approach.
    Minicocci I; Prisco C; Montali A; Di Costanzo A; Ceci F; Pigna G; Arca M
    Atherosclerosis; 2015 Oct; 242(2):618-24. PubMed ID: 26342331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High frequency of a retinoid X receptor gamma gene variant in familial combined hyperlipidemia that associates with atherogenic dyslipidemia.
    Nohara A; Kawashiri MA; Claudel T; Mizuno M; Tsuchida M; Takata M; Katsuda S; Miwa K; Inazu A; Kuipers F; Kobayashi J; Koizumi J; Yamagishi M; Mabuchi H
    Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):923-8. PubMed ID: 17272748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Pro12A1a substitution in the peroxisome proliferator activated receptor gamma 2 is associated with an insulin-sensitive phenotype in families with familial combined hyperlipidemia and in nondiabetic elderly subjects with dyslipidemia.
    Pihlajamäki J; Miettinen R; Valve R; Karjalainen L; Mykkänen L; Kuusisto J; Deeb S; Auwerx J; Laakso M
    Atherosclerosis; 2000 Aug; 151(2):567-74. PubMed ID: 10924736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A genome scan for familial combined hyperlipidemia reveals evidence of linkage with a locus on chromosome 11.
    Aouizerat BE; Allayee H; Cantor RM; Davis RC; Lanning CD; Wen PZ; Dallinga-Thie GM; de Bruin TW; Rotter JI; Lusis AJ
    Am J Hum Genet; 1999 Aug; 65(2):397-412. PubMed ID: 10417282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fine mapping of Hyplip1 and the human homolog, a potential locus for FCHL.
    Pajukanta P; Bodnar JS; Sallinen R; Chu M; Airaksinen T; Xiao Q; Castellani LW; Sheth SS; Wessman M; Palotie A; Sinsheimer JS; Demant P; Lusis AJ; Peltonen L
    Mamm Genome; 2001 Mar; 12(3):238-45. PubMed ID: 11252174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linkage of a candidate gene locus to familial combined hyperlipidemia: lecithin:cholesterol acyltransferase on 16q.
    Aouizerat BE; Allayee H; Cantor RM; Dallinga-Thie GM; Lanning CD; de Bruin TW; Lusis AJ; Rotter JI
    Arterioscler Thromb Vasc Biol; 1999 Nov; 19(11):2730-6. PubMed ID: 10559018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two polymorphisms in the apo A-IV gene and familial combined hyperlipidemia.
    Groenendijk M; De Bruin TW; Dallinga-Thie GM
    Atherosclerosis; 2001 Oct; 158(2):369-76. PubMed ID: 11583715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel genes for familial combined hyperlipidemia.
    Aouizerat BE; Allayee H; Bodnar J; Krass KL; Peltonen L; de Bruin TW; Rotter JI; Lusis AJ
    Curr Opin Lipidol; 1999 Apr; 10(2):113-22. PubMed ID: 10327279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replication of linkage of familial combined hyperlipidemia to chromosome 1q with additional heterogeneous effect of apolipoprotein A-I/C-III/A-IV locus. The NHLBI Family Heart Study.
    Coon H; Myers RH; Borecki IB; Arnett DK; Hunt SC; Province MA; Djousse L; Leppert MF
    Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2275-80. PubMed ID: 11031215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Support for linkage of familial combined hyperlipidemia to chromosome 1q21-q23 in Chinese and German families.
    Pei W; Baron H; Müller-Myhsok B; Knoblauch H; Al-Yahyaee SA; Hui R; Wu X; Liu L; Busjahn A; Luft FC; Schuster H
    Clin Genet; 2000 Jan; 57(1):29-34. PubMed ID: 10733233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of chromosome 1q21-q23 to familial combined hyperlipidemia in Mexican families.
    Huertas-Vázquez A; del Rincón JP; Canizales-Quinteros S; Riba L; Vega-Hernández G; Ramírez-Jiménez S; Aurón-Gómez M; Gómez-Pérez FJ; Aguilar-Salinas CA; Tusié-Luna MT
    Ann Hum Genet; 2004 Sep; 68(Pt 5):419-27. PubMed ID: 15469419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New genetic variants in the apoA-I and apoC-III genes and familial combined hyperlipidemia.
    Groenendijk M; Cantor RM; De Bruin TW; Dallinga-Thie GM
    J Lipid Res; 2001 Feb; 42(2):188-94. PubMed ID: 11181747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1).
    Pajukanta P; Lilja HE; Sinsheimer JS; Cantor RM; Lusis AJ; Gentile M; Duan XJ; Soro-Paavonen A; Naukkarinen J; Saarela J; Laakso M; Ehnholm C; Taskinen MR; Peltonen L
    Nat Genet; 2004 Apr; 36(4):371-6. PubMed ID: 14991056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unraveling the complex genetics of familial combined hyperlipidemia.
    Suviolahti E; Lilja HE; Pajukanta P
    Ann Med; 2006; 38(5):337-51. PubMed ID: 16938803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic dissection of familial combined hyperlipidemia.
    Eurlings PM; van der Kallen CJ; Geurts JM; van Greevenbroek MM; de Bruin TW
    Mol Genet Metab; 2001; 74(1-2):98-104. PubMed ID: 11592807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haplotypes of the ApoA-I/C-III/A-IV gene cluster and familial combined hyperlipidemia.
    Tahvanainen E; Pajukanta P; Porkka K; Nieminen S; Ikävalko L; Nuotio I; Taskinen MR; Peltonen L; Ehnholm C
    Arterioscler Thromb Vasc Biol; 1998 Nov; 18(11):1810-7. PubMed ID: 9812922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common genetic variants contribute to primary hypertriglyceridemia without differences between familial combined hyperlipidemia and isolated hypertriglyceridemia.
    De Castro-Orós I; Cenarro A; Tejedor MT; Baila-Rueda L; Mateo-Gallego R; Lamiquiz-Moneo I; Pocoví M; Civeira F
    Circ Cardiovasc Genet; 2014 Dec; 7(6):814-21. PubMed ID: 25176936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.